Is propofol a sedative‑hypnotic agent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Propofol a Sedative?

Yes, propofol is definitively a sedative-hypnotic agent used for induction and maintenance of anesthesia and procedural sedation. 1

Classification and Mechanism

Propofol (2,6-diisopropylphenol) is classified as an intravenous sedative-hypnotic agent with no analgesic properties 2. The FDA label explicitly describes it as "an intravenous general anesthetic and sedation drug" 1. It produces its sedative and anesthetic effects through positive modulation of GABA-A receptors, enhancing the inhibitory neurotransmitter GABA 1.

Clinical Characteristics

Pharmacodynamic Profile:

  • Onset: Induces anesthesia within 40 seconds from start of injection (one arm-brain circulation time) 1
  • Blood-brain equilibration: 1-3 minutes 1
  • Effect: Provides both sedative and amnestic effects 2
  • Depth: Sedation depth increases in dose-dependent manner 1

Approved Uses

The drug is FDA-approved for multiple sedation contexts 1:

  • Induction and maintenance of general anesthesia
  • Monitored anesthesia care (MAC) sedation
  • ICU sedation in intubated, mechanically ventilated patients

Important Caveats

Propofol is NOT an analgesic - it has no pain-relieving properties 2. This is a critical distinction; patients requiring pain control need concurrent opioid administration.

Cardiorespiratory depression is the primary safety concern. The drug causes 1:

  • Arterial hypotension (sometimes >30% decrease)
  • Dose-dependent respiratory depression
  • Frequent apnea during induction (43% of adults experience apnea >30 seconds)

The FDA label states propofol "should be administered only by persons trained in the administration of general anesthesia" 2, though gastroenterology guidelines support trained non-anesthesiologist administration for endoscopic procedures under specific protocols 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.